Plenvu is a Kit in the Human Prescription Drug category. It is labeled and distributed by Salix Pharmaceuticals, In. The primary component is .
Product ID | 65649-400_46e1600f-4fd7-4189-9268-2bf48086c855 |
NDC | 65649-400 |
Product Type | Human Prescription Drug |
Proprietary Name | Plenvu |
Generic Name | Polyethylene Glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Ascorbic Acid, Sodium |
Dosage Form | Kit |
Marketing Start Date | 2018-05-04 |
Marketing Category | NDA / NDA |
Application Number | NDA209381 |
Labeler Name | Salix Pharmaceuticals, In |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-05-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA209381 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-05-04 |
Marketing Category | NDA |
Application Number | NDA209381 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-05-04 |
SPL SET ID: | 79f930fa-5674-4f30-8ae8-9448d6243797 |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PLENVU 79187028 5116648 Live/Registered |
Velinor AG 2016-03-02 |